Biblio

Export 3166 results:
Author [ Title(Desc)] Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
H. - B. Kim, Park, B., and Shim, J. - Y., “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
C. Zhang, Zhang, Y., Shen, Y., Zhao, G., Xie, Z., and Dong, Y., “Anesthesia/Surgery Induces Cognitive Impairment in Female Alzheimer's Disease Transgenic Mice.”, J Alzheimers Dis, vol. 57, no. 2, pp. 505-518, 2017.
S. Yasar, Moored, K. D., Adam, A., Zabel, F., Chuang, Y. - F., Varma, V. R., and Carlson, M. C., “Angiotensin II Blood Levels Are Associated with Smaller Hippocampal and Cortical Volumes in Cognitively Normal Older Adults.”, J Alzheimers Dis, vol. 75, no. 2, pp. 521-529, 2020.
P. Gavin Kehoe, Hibbs, E., Palmer, L. E., and J Miners, S., “Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology.”, J Alzheimers Dis, vol. 58, no. 1, pp. 203-214, 2017.
J. Denner, Tanzi, R., and Jacobson, S., “Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus.”, J Alzheimers Dis, vol. 77, no. 2, pp. 543-545, 2020.
C. Weimar, Winkler, A., Dlugaj, M., Lehmann, N., Hennig, F., Bauer, M., Kröger, K., Kälsch, H., Mahabadi, A. - A., Dragano, N., Moebus, S., Hoffmann, B., Jöckel, K. - H., and Erbel, R., “Ankle-Brachial Index but Neither Intima Media Thickness Nor Coronary Artery Calcification is Associated With Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 2, pp. 433-42, 2015.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., “ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.”, J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
R. Fenoll, Pujol, J., Esteba-Castillo, S., de Sola, S., Ribas-Vidal, N., García-Alba, J., Sánchez-Benavides, G., Martínez-Vilavella, G., Deus, J., Dierssen, M., Novell-Alsina, R., and de la Torre, R., “Anomalous White Matter Structure and the Effect of Age in Down Syndrome Patients.”, J Alzheimers Dis, vol. 57, no. 1, pp. 61-70, 2017.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., “Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40.”, J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
C. C. Hays, Zlatar, Z. Z., Meloy, M. J., Osuna, J., Liu, T. T., Galasko, D. R., and Wierenga, C. E., “Anterior Cingulate Structure and Perfusion Is Associated with Cerebrospinal Fluid Tau Among Cognitively Normal Older Adult APOEɛ4 Carriers.”, J Alzheimers Dis, vol. 73, no. 1, pp. 87-101, 2020.
A. Belkacemi and Ramassamy, C., “Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State.”, J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., “The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.”, J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., “Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies.”, Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
I. Maezawa, Zou, B., Di Lucente, J., Cao, W. S., Pascual, C., Weerasekara, S., Zhang, M., Xie, X. Simon, Hua, D. H., and Jin, L. - W., “The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule.”, J Alzheimers Dis, vol. 58, no. 2, pp. 559-574, 2017.
A. Hatami, Monjazeb, S., and Glabe, C., “The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils.”, J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., “Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
T. E. Golde, Schneider, L. S., and Koo, E. H., “Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.”, Neuron, vol. 69, no. 2, pp. 203-13, 2011.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, “Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., “Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.”, J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.
E. C. K. Tan, Eriksdotter, M., Garcia-Ptacek, S., Fastbom, J., and Johnell, K., “Anticholinergic Burden and Risk of Stroke and Death in People with Different Types of Dementia.”, J Alzheimers Dis, vol. 65, no. 2, pp. 589-596, 2018.
A. Ivan B. Posis, Tarraf, W., Gonzalez, K. A., Soria-Lopez, J. A., Léger, G. C., Stickel, A. M., Daviglus, M. L., Lamar, M., Zeng, D., and González, H. M., “Anticholinergic Drug Burden and Neurocognitive Performance in the Study of Latinos-Investigation of Neurocognitive Aging.”, J Alzheimers Dis, vol. 86, no. 1, pp. 53-65, 2022.
P. Lampela, Tolppanen, A. - M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Taipale, H., “Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 119-128, 2017.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., “Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
H. Taipale, Lampela, P., Koponen, M., Tanskanen, A., Tiihonen, J., Hartikainen, S., and Tolppanen, A. - M., “Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.”, J Alzheimers Dis, vol. 68, no. 1, pp. 127-136, 2019.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., “Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.”, J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.

Pages